Drug
Bedaquiline
Bedaquiline: highest development phase Approved, developed by Johnson & Johnson. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| SIRTURO | Approved |
Latest
- SIRTURO: patent 7498343 expires 2026-12-01
Follow Bedaquiline on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.